NNVC stock: buy or sell?

NNVC stock price: $0.25 0.00% At close on May 21st, 2019

Updated on:
May 21st, 2019


NanoViricides ended today at $0.25 and stayed constant a tight 0.00%.

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections.

Should I buy NNVC stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with NanoViricides stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is NanoViricides stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for NNVC stock for the last month.

NNVC stock analysis

Daily outlook

NanoViricides ended today at $0.25 and stayed stable a tight 0.00%.

NanoViricides shares stayed stable 0.00% to $0.25 today. Since price and SMA200d lines crossed down on March, NNVC fell $-0.14 per share (-35.90%).

NNVC stock chart (daily)

Weekly outlook

NanoViricides eased a godawful -3.85% this week. Late April NNVC plunged a scary -8.00% in just one week. Early April NNVC boosted a dazzling 7.14% in just one week.

Since price and 40-weeks moving average lines crossed down early March, NNVC fell $-0.14 per share (-35.90%). Stocks below the 40w moving average line are usually not recommended for average traders.

NNVC stock chart (weekly)

NNVC stock price history

NNVC stock went public on October 26th, 2005 with a price of $1.931. Since then, NNVC stock lost a -87.00%, with a yearly average of -6.70%.

1: Adjusted price after possible price splits or reverse-splits.

NNVC stock historical price chart

NNVC stock reached 52-week highs on February at $0.68, and all-time highs 2006-03-21 with a price of 13.13.

NNVC stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' NNVC stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price prediction for NanoViricides stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since last February, when NanoViricides published its last earnings report, it plunged a scary -41.86%. Unfortunately, reported EPS is not yet available in our database.
NNVC earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In , NanoViricides annual turnover to million dollars from marked in . , its earnings margin (compared to sales) to , that is million.

NNVC annual Sales and Income evolution

Quarterly financial results

Reported quarter income marked $-2.23 million with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, NanoViricides sales marked a neutral movement and remained constant a nan%. Looking back to recent quarterly results, NanoViricides posted 7 negative quarters in a row.
NNVC quarterly Sales and Income evolution

NanoViricides ownership

When you are planning to invest in a stock, it's worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For NanoViricides, 28.05% of all outstanding shares are owned by its staff.

In case of NanoViricides stock, 5.03% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for NNVC stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related stocks:

Market cap$19.1 M$398.1 M$383.9 M$77.8 B$174.1 M
Total shares76.5 M138.7 M110.3 M1,640.0 M51.1 M
Float shares49.3 M124.7 M62.3 M1,630.0 M37.8 M
  - Institutional holdings (%)5.0%78.6%93.6%75.0%82.0%
  - Insider holdings (%)28.1%0.1%1.0%0.1%2.5%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

NNVC summary

Tuesday, May 21st, 2019
Day range$0.25 - $0.26
Previous close$0.25
Session gain0.00%
Average true range$0.02
50d mov avg$0.27
100d mov avg$0.30
200d mov avg$0.32
Daily pattern
Weekly pattern lb06a

NanoViricides performance

To measure stock performance is always good to compare with competitors or related stocks. For NanoViricides, the comparison is made against Achillion Pharmaceuticals, BioCryst Pharmaceuticals, Bristol-Myers Squibb, Chimerix, Gilead Sciences, GlaxoSmithKline, Merck and NovaBay Pharmaceuticals.
ACHNAchillion Pharmac...14.80%-1.71%-20.06%
BCRXBioCryst Pharmace...-61.33%-62.78%-42.76%
BMYBristol-Myers Squ...-6.13%-8.89%-7.36%
GILDGilead Sciences2.17%1.71%2.12%
NBYNovaBay Pharmaceu...-73.88%-71.07%-86.27%

NanoViricides competitors

We chose a few stocks to conform a list of NanoViricides competitors to review if you are interested in investing in NNVC: